BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19010845)

  • 1. Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.
    Micha D; Cummings J; Shoemaker A; Elmore S; Foster K; Greaves M; Ward T; Rosenberg S; Dive C; Simpson K
    Clin Cancer Res; 2008 Nov; 14(22):7304-10. PubMed ID: 19010845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
    Cummings J; Hodgkinson C; Odedra R; Sini P; Heaton SP; Mundt KE; Ward TH; Wilkinson RW; Growcott J; Hughes A; Dive C
    Mol Cancer Ther; 2008 Mar; 7(3):455-63. PubMed ID: 18347133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
    de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
    Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
    Dean EJ; Cummings J; Roulston A; Berger M; Ranson M; Blackhall F; Dive C
    Neoplasia; 2011 Apr; 13(4):339-47. PubMed ID: 21472138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
    Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
    Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatments with ABT-263 and an immunotoxin produce synergistic killing of ABT-263-resistant small cell lung cancer cell lines.
    Mattoo AR; FitzGerald DJ
    Int J Cancer; 2013 Feb; 132(4):978-87. PubMed ID: 22821746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
    Risberg K; Fodstad Ø; Andersson Y
    PLoS One; 2011; 6(9):e24012. PubMed ID: 21915275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
    Zinn RL; Gardner EE; Dobromilskaya I; Murphy S; Marchionni L; Hann CL; Rudin CM
    Mol Cancer; 2013 Mar; 12():16. PubMed ID: 23452820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Heat Shock Protein 90α Attenuated the Effect of Anticancer Drugs in Small-Cell Lung Cancer Cells Through AKT/GSK3β/β-Catenin Signaling.
    Du Y; Wu J; Luo L
    Cancer Control; 2018; 25(1):1073274818804489. PubMed ID: 30282477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737.
    Mani J; Antonietti P; Rakel S; Blaheta R; Bartsch G; Haferkamp A; Kögel D
    World J Urol; 2016 Feb; 34(2):197-205. PubMed ID: 26100943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.
    Hou JM; Greystoke A; Lancashire L; Cummings J; Ward T; Board R; Amir E; Hughes S; Krebs M; Hughes A; Ranson M; Lorigan P; Dive C; Blackhall FH
    Am J Pathol; 2009 Aug; 175(2):808-16. PubMed ID: 19628770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.
    Kim KW; Moretti L; Mitchell LR; Jung DK; Lu B
    Clin Cancer Res; 2009 Oct; 15(19):6096-105. PubMed ID: 19773376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.
    Hann CL; Daniel VC; Sugar EA; Dobromilskaya I; Murphy SC; Cope L; Lin X; Hierman JS; Wilburn DL; Watkins DN; Rudin CM
    Cancer Res; 2008 Apr; 68(7):2321-8. PubMed ID: 18381439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH; Kandasamy K; Kraft AS
    J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.
    Kim EY; Jung JY; Kim A; Chang YS; Kim SK
    Neoplasia; 2017 Apr; 19(4):354-363. PubMed ID: 28319809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
    Simpson KL; Cawthorne C; Zhou C; Hodgkinson CL; Walker MJ; Trapani F; Kadirvel M; Brown G; Dawson MJ; MacFarlane M; Williams KJ; Whetton AD; Dive C
    Cell Death Dis; 2013 May; 4(5):e613. PubMed ID: 23640455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737.
    Hauck P; Chao BH; Litz J; Krystal GW
    Mol Cancer Ther; 2009 Apr; 8(4):883-92. PubMed ID: 19372561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
    Yu X; Dobrikov M; Keir ST; Gromeier M; Pastan IH; Reisfeld R; Bigner DD; Chandramohan V
    PLoS One; 2019; 14(1):e0210608. PubMed ID: 30625226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model.
    Lee JM; Kim HS; Kim A; Chang YS; Lee JG; Cho J; Kim EY
    Yonsei Med J; 2022 Jan; 63(1):16-25. PubMed ID: 34913280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.